Beruflich Dokumente
Kultur Dokumente
PHARMACYDAILY.COM.AU
Osteoarthritis CMs
A NEW study published in the Annals of Rheumatic Diseases has demonstrated that the glucosamine-chondroitin combination conferred a benefit for osteoarthritis patients. The study was a double-blind randomised placebo-controlled clinical trial with two year follow up. 605 participants aged 45 to 75years with chronic knee pain and evidence of medial tibiofemoral compartment narrowing or joint space narrowing (JSN) were included in the research. Dosing was 1500 mg of glucosamine sulfate and 800 mg of chondroitin sulfate. A statistically significant reduction in JSN at twoyears was recorded for the treated group supporting previous studies with this combination. CLICK HERE to read the abstract.
PreSeNtiNG at the 2014 APP conference will be Dr Judith Smith, director of policy at the Nuffield Trust in the United Kingdom, and a co-author of Now or never: Shaping Pharmacy for the Future arguably one of the most important reports on pharmacy to emerge in many years said a Guild spokesperson (PD 16 Jan). The report, which was commissioned by the Royal Pharmaceutical Society, was welcomed by the Guild as a critically seminal piece reinforcing the need for community pharmacy to transform and innovate in difficult times. The Guild added that the report summarised the same challenges facing community pharmacy in Australia, namely that the current model of community pharmacy needs to change, forced by the
Therapeutic sunscreen
the Therapeutic Goods Administration (TGA) has provided a useful update on sunscreen protection reminding that sunscreens with a Sunscreen Protection Factor (SPF) of 4 or more and insect repellents with sunscreen with an SPF of 4 or more and moisturisers with sunscreen and an SPF greater than 15 are therapeutic sunscreens. To read the sunscreen update and other updates from the TGA, go to www.tga.gov.au.
www.doseinnovations.com
w www.pharmacydaily.com.au
page 1
IHP2853 - 01/14
Inner Health Immune Booster for Kids may help reduce the frequency and severity of cold symptoms, such as runny noses and coughs, and reduce the days away from childcare and school.
Follow us on:
Thursday 30 Jan 2014 PHARMACYDAILY.COM.AU
Just one click away from keeping up to date with all the breaking news as it comes to hand...
FeetFirst PA training
FEETFIRST is RBs foot health training program for pharmacy assistants to help them provide treatment and prevention support to patients with foot conditions. R&Bs Scholl brand has sponsored Gemma Howorth, an international foot model who has modelled her feet (pictured) for people such as Kate Moss, Rose Byrne, January Jones and Heidi Klum, to visit Australia and help promote good foot care. Gemmas message is to take three simple steps: exfoliate, tone and moisturise. To learn more about FeetFirst, visit www.rbhealthhub.com.au.
Every day this week Pharmacy Daily and MeMeMe Cosmetics are giving away Arch Angel brow kit and Lash Attack Mascara. Beauty has a new obsession... British boutique brand MeMeMe cosmetics award winnning Arch Angel is your ultimate secret weapon for bang on trend brows. Use this clever brow gel/highlighter combo to lift, brighten, tame and shape the brows. Teamed with MeMeMe Lash Attack Mascara and formulated with fibrelash technology for high impact lashes, this duo gives you all you need to set yourself apart from the crowd. To win, be the first person to send in the correct answer to the question below to comp@pharmacydaily.com.au.
w www.pharmacydaily.com.au
Advertise with us
For details call us today: 1300 799 220
Thursday 30 Jan 2013 PHARMACYDAILY.COM.AU
Travel Specials
WELCOME to Pharmacy Dailys travel feature. Each week we highlight a couple of great travel deals for the pharmacy industry, brought to you by Cruise Weekly.
Multivitamins in pregnancy
A NEW study from Denmark has indicated there may be a modest increase of early foetal death associated with the use of multivitamins during pregnancy. For late foetal death, the study concluded that there may be a decreased risk. The authors said the data is not strong or conclusive either way and should not dramatically influence behaviour relating to vitamins during pregnancy. Further studies on preconceptional multivitamin use are needed to guide public health recommendations, they conclude. Published in the International Journal of Epidemiology and titled Periconceptional intake of vitamins and fetal death: a cohort study on multivitamins and folate, the study involved 35,914 women in the Danish National Birth Cohort who at recruitment had reported the number of weeks of supplement use during a 12-week periconceptional period. The main takeaway message was summarised in the accompanying editorial which said that the study should not be interpreted as evidence against current recommendations for folate supplementation. Neither is there strong enough reason to conclude that folate-only supplements should be preferred over multivitamins. To access the abstract of the study, CLICK HERE.
www.cruiseweekly.com.au
Travel Associates is offering a three night package at the Regent Bali, the only all-suites beachfront resort in Sanur. Surrounded by 10 acres of tropical gardens, the Regent Bali has 94 suites including spa suites with separate spa treatment rooms. The package is priced from $779 per person twin share and includes accommodation in a deluxe garden view room, daily breakfast, a 24 hour butler service and a scheduled resortSanur area shuttle service. Valid until 15 Apr for travel from 15 Jun to 14 Jul, 01 Sep to 27 Dec this year and 06 Jan to 28 Mar 2015, to book contact Travel Associates on 1800 017 849. Or join APT as it celebrates the launch of a new collection of luxury small group holidays to India with one of three special deals. For example, the 14 day Spirit of India from Delhi to Kolkata is priced from $9,695, with your companion flying to India for free, including air taxes of up to $780 per person. The package starts with a six night land journey from New Delhi, then a seven night Lower Ganges River cruise aboard the new RV Ganges Voyager luxury river ship. Deals are valid on all bookings until 31 May or until sold out. For more information on other deals or in general, call APT on 1300 278 278.
Nudging antibiotics
A STUDY published in JAMA Internal Medicine found that displaying poster-sized commitment letters in exam rooms decreased inappropriate antibiotic prescribing for acute respiratory infections (ARI). The study investigated the use of behavioural nudges to influence decision making. There were 954 adults with ARI visits during the three weeks of the study and the nudge consisted of poster-sized letters committing to avoiding inappropriate antibiotic prescribing. The study found that the posted letter resulted in a 19.7% reduction in inappropriate antibiotic prescribing rate relative to control. NPS MedicineWise urged health professionals to pledge to fight antibiotic resistance in wake of the research. To access the study, CLICK HERE.
DISPENSARY CORNER
IM sharked. If youre selling bandages to anyone, take a moment to think about James Grant, a Kiwi junior doctor who, when attacked by a shark, sewed up his wounds before heading to the pub for a beer - then to hospital. Grant was fishing at Garden Bay when a shark had the same idea, biting his leg and detaching only when Grant had given the shark a few stabs with a knife which he lamented was too short, the Southland Times reported. Grant used a needle and thread from a first-aid kit for his pighunting dogs while waiting for his friends to finish spearfishing, after which they took him to the local pub, who served him a beer and some bandages to stop his dripping on the carpet, and then hospital for stitches, the publication reported. COW bomb. Gassy cow is no longer just an insult - its now the cause of an explosion which damaged the roof of a farm shed in Germany. Methane gas from 90 flatulent bovines built up in the shed, located in Rasdorf, until a static electric charge caused the gas to explode with flashes of flame, Reuters reported. One cow was treated for burns, the publication said.
Amgen, Pfizer Q4
PfiZer Inc and Amgen have reported fourth quarter results, with Amgen pulling in profit of US$1b, up 30% year on year. Revenue rose 13% to US$5b, with full year up 8% to US$18.7b. GAAP net income for the full year was US$5b, up 17% year on year. Meanwhile Pfizers Q4 net income of US$2.57b, compared with US$6.32b for the year ago period, nevertheless beat estimates, MarketWatch reported. Sales were US$13.56b compared with the previous years US$13.89b, with revenues coming in at US$13.6b, down 2% year on year.
US IV saline shortage
The Food and Drug Administration (FDA) is working with three intravenous saline solution manufacturers to address a shortage. The FDA said the shortage, particularly of the saline injection, had been triggered by a range of factors including a reported increased hospital demand, possibly related to the flu season. The FDA has said it was working with Baxter International Inc, Hospira Inc and B. Braun Medical Inc to minimise the impact of the shortage.
editors Bruce Piper, Alex Walls & Mal Smith email info@pharmacydaily.com.au advertising Magda Herdzik advertising@pharmacydaily.com.au page 3
Pharmacy Daily is a publication for health professionals of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission from the editor to reproduce any material. While every care has been taken in the preparation of Pharmacy Daily no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial is taken by Bruce Piper.